Register Login

All Posts

Factor XIII Concentrate

In February 2011, the plasma-derived CLS Behring factor XIII concentrate Corifact™received US Food and Drug Administration (FDA) clearance to provide bleeding prophylaxis for patients with rare congenital factor XIII (fibrin stabilizing factor) deficiency. In January, 2013, the FDA extended Corifact’s indication to include management of perioperative bleeding in factor XIII-deficient patients. The Corifact package insert is attached here: Corifact Prescribing […]
read more

Laboratory Testing and Standardization

With a thanks for the heads-up to Elaine Benoit, Precision BioLogic Inc, here is a fascinating retrospective on Hemophilia testing, Barrowcliffe TW, Laboratory testing and standardisation. Haemophilia 2013;19:799–804, in the November, 2013 edition of the Journal, Haemophilia, publication of the World Federation of Haemophilia. Click here for the article: Barrowcliffe: Laboratory Testing and Standardisation
read more